Interviews and Discussions With Fascinating People Who are Creating A Better Tomorrow For All Of Us - Host - Ira S. Pastor
Nuclear power has a scale problem: conventional plants are enormous, expensive projects that can take years to build. Hadron Energy wants to take a different approach with a factory-manufactured, 10-megawatt light-water microreactor. But can a smaller reactor actually mean lower costs, simpler deployment and credible safety?
Sam Gibson is Founder and CEO of Hadron Energy ( https://www.hadronenergy.com/ ...
The world doesn't have a shortage of promising medical discoveries. The real challenge is turning those discoveries into safe, effective, accessible treatments. What separates a breakthrough idea from a successful therapy? How could AI change the economics of drug development? And can regenerative medicine move healthcare beyond managing disease toward restoring damaged tissue? Today, we're tackling these questions ...
What if we stopped thinking about antibodies as simply drugs that bind to one target - and started thinking about them as engineered molecular machines? Today we're talking about a bispecific antibody that targets both EGFR and LGR5, and asking whether that kind of antibody engineering could actually change the treatment landscape for head and neck cancer.
Dr. Tahamtan Ahmadi, MD, Ph.D. is Executive Vice Pres...
What happens when you're 19 years old, physically fit, a collegiate wrestler, and you suddenly find yourself hospitalized for three days with influenza? Today's guest, Zachery Lang, experienced exactly that - and his story offers an important perspective on a disease many of us underestimate.
Zachery Lang ( https://familiesfightingflu.org/family-story/the-lang-family/ ) is a student at Indiana University and ...
Homelessness, addiction, mental health, aging and incarceration are often treated as separate problems. But for the people experiencing them, they're frequently connected. What would it take to build a system that sees the whole person - and could emerging technology help us get there?
Ericka Fusilier is Executive Vice President of External Affairs at VOA ( https://www.voa.org/ - formerly known as...
What if the next breakthrough in diabetes treatment isn't necessarily a new drug molecule, but a better way to deliver the drugs we already have? One biotechnology company is developing a platform designed to target the liver with insulin - and exploring whether the same principle could eventually apply to GLP-1 and other metabolic therapies. Today, we're exploring the science, the clinical evidence, and what still ...
Cancer medicine is advancing rapidly. But are patients getting the tests and treatments they need to benefit from those advances?
Chronic lymphocytic leukemia, or CLL, is one of the most common forms of adult leukemia. And while advances in targeted therapies have transformed the treatment landscape, a critical question remains: Are patients actually getting access to the right tests, the right treatments, an...
The brain is one of the most complex systems in biology, and understanding it requires more than a picture of its anatomy. We need to understand its connections, activity, and response to injury.
Today we're going to ask a fascinating question: Can advanced neuroimaging and artificial intelligence give us a much better understanding of what happens to the brain after injury and disease - and ultimately ...
We usually assume that before we can use electricity somewhere, we need to build the infrastructure to deliver it. But what if we could bring the energy infrastructure to the location instead? That's the idea behind Beam Global's approach to solar-powered EV charging, energy storage, and resilient power.
Desmond Wheatley is President, CEO, and Chairman of the Board of Beam Global ( https://beamforall.com/ ), ...
A drug can look promising in the laboratory and still fail when it reaches human testing. One of the biggest challenges in drug development is predicting what a compound will actually do inside the human body - including whether it will cause dangerous side effects. Could AI help us make those predictions more accurately, before patients are ever exposed?
Dr. Natalie Ma, Ph.D. is Chief Business Officer and a ...
What happens when your ADHD medication wears off, but your day isn't over? Homework, family responsibilities, relationships, and everything else still demand your attention. So why are we still thinking about ADHD treatment in terms of the school day or the workday? Today, we're exploring whether a different approach to drug delivery could change that.
Today we're going to take a fascinating look at ADHD trea...
What if a promising drug fails a clinical trial not because the drug doesn't work, but because it works for a subset of patients whose response gets lost in the averages? What if AI could help us find those patients hidden inside the data? That's the challenge we're exploring today with mathematical scientist Dr. Joseph Geraci, Ph.D., co-founder and chief technology and science officer at NetraMark ( https://www.net...
We've been automating laboratories for decades. Robots can pipette, instruments can run assays, and computers can analyze enormous datasets. But that's not necessarily an autonomous laboratory.
The really interesting question is: what happens when the system itself can decide what experiment should come next?
AI proposes. Robots execute. Instruments measure. The data goes back into the model - and the ...
What if you could treat a genetic disease without actually fixing the defective gene?
That's the fascinating idea behind a new approach being developed for devastating pediatric lysosomal storage disorders. These diseases can have completely different genetic causes - but ultimately disrupt some of the same cellular machinery.
So instead of trying to correct every individual mutation, could we enhance ...
Cancer treatment can save a patient's life - but what happens when the treatment itself leaves them struggling with pain, fatigue, weakness, limited mobility, or other lasting physical effects? Cancer rehabilitation is changing how we think about recovery, helping patients prepare for treatment, maintain their function, and regain their independence.
Cancer treatment has made remarkable advances, dramatically...
We have some of the most powerful AI systems in history - but what if one of the biggest obstacles to using AI to solve biology isn't the algorithms? What if it's the data?
There are enormous amounts of biological data sitting inside pharmaceutical companies, biotech companies and research institutions. The problem is that much of it is proprietary - and the organizations that spent millions generating it hav...
What if we could look inside the breast without X-rays, without compression, and without injecting a contrast agent - and instead use sound to create a three-dimensional map of the tissue?
Dr. Raluca Dinu, Ph.D. is Chief Executive Officer of QT Imaging ( https://www.qtimaging.com/ ), a medical technology company developing quantitative, three-dimensional breast imaging using transmission and reflection ultras...
There are tens of millions of Americans quietly caring for a parent, spouse, child or loved one - often while trying to maintain a career and a normal life. Yet much of that work is essentially invisible to our healthcare system, our economy and even our data infrastructure.
Richard Lui ( https://richardlui.com/ ) is an award-winning journalist, filmmaker, author, entrepreneur, and nationally recognized careg...
A robot can see you.
It can recognize you.
It can track where you're moving.
But can it understand what you're trying to do?
Because humans don't simply move through the world - we constantly interpret one another's intentions, expectations, emotions and behavior.
And as AI-powered robots move from factories into restaurants, hospitals, hotels, stores and eventually our homes, that...
Your face can now be turned into a mathematical representation, searched against enormous databases, and potentially matched in fractions of a second. But what happens when AI moves beyond recognizing your face - and starts understanding everything happening around you?
B. Scott Swann is CEO of ROC ( https://roc.ai/ ), formerly known as Rank One Computing, a company developing AI-powered biometric identity, v...
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
The Clay Travis and Buck Sexton Show. Clay Travis and Buck Sexton tackle the biggest stories in news, politics and current events with intelligence and humor. From the border crisis, to the madness of cancel culture and far-left missteps, Clay and Buck guide listeners through the latest headlines and hot topics with fun and entertaining conversations and opinions.
Does hearing about a true crime case always leave you scouring the internet for the truth behind the story? Dive into your next mystery with Crime Junkie. Every Monday, join your host Ashley Flowers as she unravels all the details of infamous and underreported true crime cases with her best friend Brit Prawat. From cold cases to missing persons and heroes in our community who seek justice, Crime Junkie is your destination for theories and stories you won’t hear anywhere else. Whether you're a seasoned true crime enthusiast or new to the genre, you'll find yourself on the edge of your seat awaiting a new episode every Monday. If you can never get enough true crime... Congratulations, you’ve found your people. Follow to join a community of Crime Junkies! Crime Junkie is presented by Audiochuck Media Company.
DISGRACELAND is an award-winning music and true crime podcast about musicians getting away with murder and behaving very badly. Jerry Lee Lewis's 5th wife? Dead. Sid and Nancy? Both dead. Why? Because musicians are insane, and insane things happen to them. Why did we lose Amy Winehouse at 27? Was Debbie Harry really abducted by Ted Bundy as she claims? Is Patti Smith not just the "Godmother of Punk", but also the "Original True Crime Girl"? What really happened the night of the Jay Z nightclub stabbing? What do the Diddy indictments truly reveal? All these stories and more, on artists from every genre and their true crimes, in our massive 260-plus story archive. The Dead, the Stones, Johnny, Willie, Frank, Kurt, Courtney, Gaga, Lana, Taylor, and too many to name. DISGRACELAND is music history come to life through audio storytelling as you've never heard it before, with revealing facts: yes, assassins are the real reason the Beatles quit touring—reclaimed myths: no, Mama Cass didn't die from choking on a ham sandwich––and constant reckoning between art and artist––all told through the lens of true crime. This is the podcast for the self-proclaimed "Disgos", the musically obsessed and the true crime heads; the outsiders, the independent thinkers who know that the best history is the history that gets buried. DISGRACELAND is where host Jake Brennan tells the stories they didn't want told. The kind you'll end up telling someone else. Get ready to uncover hidden truths and buckle up for truly edge-of-your-seat storytelling. New, fully scripted, sound-designed episodes are released every Tuesday. Bonus chat-style episodes where Jake responds to voicemails, texts, and emails from Disgos hit on Thursdays, and "Rewind" episodes from our archive drop on Sundays. DISGRACELAND is not a journalistic podcast. It's an entertainment podcast inspired by true events. Certain dialogue and scenes are dramatized, as is common in scripted entertainment based on real stories. Sources and credits for each episode are available at www.disgracelandpod.com. To unlock ad-free listening, exclusive content, and connect with your fellow Disgos, go to www.disgracelandpod.com to become an All Access member. Rocka Rolla.